Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 10.
doi: 10.1038/s41586-025-09434-9. Online ahead of print.

Functional synapses between neurons and small cell lung cancer

Vignesh Sakthivelu #  1   2   3 Anna Schmitt #  2   4 Franka Odenthal #  5 Kristiano Ndoci #  6 Marian Touet #  2   7 Ali H Shaib #  8 Abdulla Chihab #  6 Gulzar A Wani  6 Pascal Nieper  1   2 Griffin G Hartmann  9   10 Isabel Pintelon  11   12 Ilmars Kisis  1   2   3 Maike Boecker  1   2   3 Naja M Eckert  1 Manoela Iannicelli Caiaffa  1   2   3 Olta Ibruli  1   2 Julia Weber  13 Roman Maresch  13 Christina M Bebber  1   6 Ali Chitsaz  1   2   3 Anna Lütz  1   2   3 Mira Kim Alves Carpinteiro  1   2   3 Kaylee M Morris  5 Camilla A Franchino  5 Jonas Benz  6 Laura Pérez-Revuelta  6 Jorge A Soriano-Campos  6 Maxim A Huetzen  2   6   14   15 Jonas Goergens  2   6   14   15 Milica Jevtic  6 Hannah M Jahn-Kelleter  6 Hans Zempel  15   16 Aleksandra Placzek  6 Alexandru A Hennrich  17 Karl-Klaus Conzelmann  17 Hannah L Tumbrink  1   18 Pascal Hunold  1   15 Joerg Isensee  19   20 Lisa Werr  21 Felix Gaedke  6 Astrid Schauss  6 Marielle Minère  6   22 Marie Müller  6   22 Henning Fenselau  6   22   23 Yin Liu  24 Alena Heimsoeth  1   15   18 Gülce S Gülcüler Balta  1   2   3 Henning Walczak  6   25   26 Christian Frezza  27   28 Ron D Jachimowicz  2   6   14   15 Julie George  1   29 Marcel Schmiel  30 Johannes Brägelmann  1   3   15 Tim Hucho  19   20 Silvia von Karstedt  1   6   15 Martin Peifer  1   15 Alessandro Annibaldi  15 Robert Hänsel-Hertsch  1   6   15   16 Thorsten Persigehl  31 Holger Grüll  31 Martin L Sos  1   32   33 Guido Reifenberger  34 Matthias Fischer  15   21 Dirk Adriaensen  11 Reinhard Büttner  30 Julien Sage  9   10 Inge Brouns  11 Roland Rad  13 Roman K Thomas  1   30 Max Anstötz  35 Silvio O Rizzoli  36   37   38 Matteo Bergami  39   40   41   42 Elisa Motori  43   44   45 Hans Christian Reinhardt  46   47   48   49 Filippo Beleggia  50   51   52
Affiliations

Functional synapses between neurons and small cell lung cancer

Vignesh Sakthivelu et al. Nature. .

Erratum in

  • Publisher Correction: Functional synapses between neurons and small cell lung cancer.
    Sakthivelu V, Schmitt A, Odenthal F, Ndoci K, Touet M, Shaib AH, Chihab A, Wani GA, Nieper P, Hartmann GG, Pintelon I, Kisis I, Boecker M, Eckert NM, Iannicelli Caiaffa M, Ibruli O, Weber J, Maresch R, Bebber CM, Chitsaz A, Lütz A, Kim Alves Carpinteiro M, Morris KM, Franchino CA, Benz J, Pérez-Revuelta L, Soriano-Campos JA, Huetzen MA, Goergens J, Jevtic M, Jahn-Kelleter HM, Zempel H, Placzek A, Hennrich AA, Conzelmann KK, Tumbrink HL, Hunold P, Isensee J, Werr L, Gaedke F, Schauss A, Minère M, Müller M, Fenselau H, Liu Y, Heimsoeth A, Gülcüler Balta GS, Walczak H, Frezza C, Jachimowicz RD, George J, Schmiel M, Brägelmann J, Hucho T, von Karstedt S, Peifer M, Annibaldi A, Hänsel-Hertsch R, Persigehl T, Grüll H, Sos ML, Reifenberger G, Fischer M, Adriaensen D, Büttner R, Sage J, Brouns I, Rad R, Thomas RK, Anstötz M, Rizzoli SO, Bergami M, Motori E, Reinhardt HC, Beleggia F. Sakthivelu V, et al. Nature. 2025 Sep 19. doi: 10.1038/s41586-025-09638-z. Online ahead of print. Nature. 2025. PMID: 40973832 No abstract available.

Abstract

Small cell lung cancer (SCLC) is a highly aggressive type of lung cancer, characterized by rapid proliferation, early metastatic spread, frequent early relapse and a high mortality rate1-3. Recent evidence has suggested that innervation has an important role in the development and progression of several types of cancer4,5. Cancer-to-neuron synapses have been reported in gliomas6,7, but whether peripheral tumours can form such structures is unknown. Here we show that SCLC cells can form functional synapses and receive synaptic transmission. Using in vivo insertional mutagenesis screening in conjunction with cross-species genomic and transcriptomic validation, we identified neuronal, synaptic and glutamatergic signalling gene sets in mouse and human SCLC. Further experiments revealed the ability of SCLC cells to form synaptic structures with neurons in vitro and in vivo. Electrophysiology and optogenetic experiments confirmed that cancer cells can receive NMDA receptor- and GABAA receptor-mediated synaptic inputs. Fitting with a potential oncogenic role of neuron-SCLC interactions, we showed that SCLC cells derive a proliferation advantage when co-cultured with vagal sensory or cortical neurons. Moreover, inhibition of glutamate signalling had therapeutic efficacy in an autochthonous mouse model of SCLC. Therefore, following malignant transformation, SCLC cells seem to hijack synaptic signalling to promote tumour growth, thereby exposing a new route for therapeutic intervention.

PubMed Disclaimer

Conflict of interest statement

Competing interests: H.C.R. received consulting and lecture fees from Abbvie, AstraZeneca, Vertex and Merck. H.C.R. received research funding from AstraZeneca and Gilead Pharmaceuticals. H.C.R. is a co-founder of CDL Therapeutics. R.K.T. is a founder of PearlRiver Bio (now part of Centessa), a shareholder of Centessa, a founder and shareholder of Epiphanes and a consultant to PearlRiver Bio and Epiphanes. R.K.T. has received research support from Roche. R.K.T. and J.S. are co-founders and shareholders of DISCO Pharmaceuticals. M.L.S. is a co-founder and was an advisor of PearlRiver Bio (now part of Centessa). M.L.S. received research funding from PearlRiver Bio (now part of Centessa). S.O.R. is a shareholder of NanoTag Biotechnologies. H.W. was a co-founder of Apogenix. J. George is a consultant to DISCO Pharmaceuticals and received honoraria from MSD and Boehringer Ingelheim. J. Brägelmann has received research funding from Bayer and travel grants from Merck and Bicycle Therapeutics. The other authors declare no competing interests.

References

    1. Dingemans, A. M. C. et al. Small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 32, 839–853 (2021). - PubMed - DOI
    1. Rudin, C. M., Brambilla, E., Faivre-Finn, C. & Sage, J. Small-cell lung cancer. Nat. Rev. Dis. Primers 7, 3 (2021).
    1. Poirier, J. T. et al. New approaches to SCLC therapy: from the laboratory to the clinic. J. Thorac. Oncol. 15, 520–540 (2020). - PubMed - PMC - DOI
    1. Zahalka, A. H. & Frenette, P. S. Nerves in cancer. Nat. Rev. Cancer 20, 143–157 (2020). - PubMed - PMC - DOI
    1. Pan, C. & Winkler, F. Insights and opportunities at the crossroads of cancer and neuroscience. Nat. Cell Biol. 24, 1454–1460 (2022). - PubMed - DOI

LinkOut - more resources